Quantcast

Posts related to ‘DNDN’

Top Analyst Upgrades & Downgrades (ASX, AAPL, BX, BRCM, CIEN, CMA, DELL, DNDN, DANG, GILD, MDT, MOS, EDU, SPIL, TSM)

These are some of this Wednesday's top analyst upgrades, downgrades, and initiations seen in Wall Street research calls. Advanced Semiconductor Engineering, Inc. (NYSE: ASX) Cut to Neutral at BofA/ML. Apple ...
Read Full Story »

24/7 Wall St. Closing Bell (FDX, WY, CMA, GLW, RDS-A, IDTI, MCK, PCL, CYOU, HUM, LAZ, L, SYY, SURW, CHUX, SOHU, GBG, DNDN)

US equity markets opened lower this morning and never moved into positive territory all day. Greek debt swap negotiations made no discernible progress today and there was no scheduled data ...
Read Full Story »

24/7 Wall St. Top Analyst Calls of the Week (T, ADP. BBY, CHK, DNDN, ETFC, JCP, JPM, GS, MS, JEF, KLAC, LIFE, MCD, KORS, NFLX, VPRT, ZNGA)

This last week brought many new analyst calls in key stocks.  At the end of each week we review research calls looking for the best gems, the calls that made ...
Read Full Story »

Tracking The highly Unusual Short Interest Trends (ALU, BAC, DNDN, DMND, FSLR, F, GMCR, HGSI, LNKD, NFLX, RIMM, SIRI)

Cult stocks and controversial stocks often have an unusually high short interest.  What is amazing is that the bets against these companies sometimes go off the charts.  We have tracked ...
Read Full Story »

Top Analyst Upgrades & Downgrades (DVA, DNDN, GS, HGG, KEY, MCD, MS, ORCL, RF, SBUX, ZNGA)

These are some of the top analyst upgrades, downgrades, and initiations seen from Wall Street brokerage and research firms this Wednesday morning. DaVita, Inc. (NYSE: DVA) Raised to Outperform as ...
Read Full Story »

2012 Top Picks From… Everyone! (AAPL, T, BA, GE, KFT, ETFC, MCP, DNDN, BSX, ISRG, STJ)

24/7 has compiled many of the predictions from various firms and various market pundits for what lies ahead in 2012.  Wall St. modified analyst consensus price target methodology generates 12% ...
Read Full Story »

Top Analyst Upgrades & Downgrades (AGCO, APOL, BSX, CECO, DNDN, FDX, GS, HUN, ITW, INTC, KSS, SNDK, AMTD, TRV, UPS, URBN, VOD, HOGS)

These are some of the top analyst upgrades, downgrades, and initiations seen from Wall Street brokerage and research firms this Friday morning. AGCO Corporation (NYSE: AGCO) Maintained Outperform as Bull ...
Read Full Story »

Short Sellers Help Push Dendreon Higher

Dendreon (NASDAQ: DNDN) soared almost 40% in value, or $3.02 a share, in active trading on Thursday after announcing that fourth-quarter revenue from its Provenge prostate-cancer vaccine would exceed earlier ...
Read Full Story »

Media Digest (1/6/2012) Reuters, WSJ, NYT, FT, Bloomberg

Former Olympus CEO Michael Woodford will sue the troubled company for wrongful dismissal. (Reuters) The International Monetary Fund’s Lagarde says 2012 will not see the end of the euro. (Reuters) MF ...
Read Full Story »

24/7 Wall St. Closing Bell (BRCM, NFLX, NOK, GOOG, VMW, STZ, MON, WOR, HELE, DNDN, ACOM, ZUMZ, OSH, BKS, AEO)

US markets opened lower today and finally managed modest gains by mid-afternoon. News from Europe on the reluctance of banks to lend, coupled with an higher-than-expected yield on a French ...
Read Full Story »

Top Biotech Stock Picks For 2012 (ARIA, DNDN, GILD, HGSI, ILMN, INCY, JAZZ, LIFE, THRX, IBB, XBI)

The biotech sector has seen its share of ups and downs in 2011 and prior years.  It is almost always the case that some of the top performing stocks each ...
Read Full Story »

Top Analyst Upgrades & Downgrades (C, COST, DO, DNDN, GOOG, HGSI, MCP, NTES, NR, POM, PCYC, SHLD, SIRI, TXN, YHOO)

These are some of the top analyst upgrades, downgrades, and initiations seen from Wall Street research calls this Friday morning. Citigroup, Inc. (NYSE: C) Started as Equal-Weight by Evercore Partners. ...
Read Full Story »

Dendreon Raising $125 Million Via I.P. Sale (DNDN, MRK)

Dendreon Corporation (NASDAQ: DNDN) is supposed to be the king of prostate cancer with its PROVENGE treatment.  Unfortunately, PROVENGE sales ran slower than expected after the FDA took forever to ...
Read Full Story »

Another Bump Up for Dendreon and PROVENGE (DNDN)

Dendreon Corporation (NASDAQ: DNDN) is surging on news that the Centers for Medicare and Medicaid Services will now cover the infusion costs associated with the administration of PROVENGE.  Dendreon noted ...
Read Full Story »

Dendreon Buyout, How Imminent?

Though near-term growth visibility for its cancer vaccine Provenge remains cloudy, Seattle-based Dendreon (DNDN) could be an attractive takeover candidate – especially to a major pharmaceutical house seeking a unique ...
Read Full Story »